74.5 F
Pakistan
Wednesday, June 3, 2026
HomeHealthElpasbio Completes Patient Enrollment In Phase III Pivotal Clinical Trial Of Allojoin®

Elpasbio Completes Patient Enrollment In Phase III Pivotal Clinical Trial Of Allojoin®

(MENAFN – PR Newswire) AlloJoin– is one of the few stem cell product candidates in late-stage clinical development worldwide ElpasBio is planning for data readout and NDA by next year ElpasBio. ..

Read full story on Menafn

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments